ReviewTherapeutic advances in hematology2020

Gilteritinib in the treatment of relapsed and refractory acute myeloid leukemia with a FLT3 mutation.

Serena Chew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.